α-Pyrrolidinobutiophenone (α-PBP) is a stimulant compound developed in the 1960sErnst Seeger. α-Pyrrolidinyl ketones. US Patent 3314970 which has been reported as a novel designer drug. It can be thought of as the homologue lying between the two better known drugs α-PPP and α-PVP.
Legality
In the United States, it is a Schedule I controlled substance.Schedules of Controlled Substances: Temporary Placement of 10 Synthetic Cathinones Into Schedule I
Sweden's public health agency suggested to classify α-PBP as hazardous substance on November 10, 2014.
As of October 2015 α-PBP is a controlled substance in China.
See also α-Pyrrolidinopropiophenone (α-PPP) α-Pyrrolidinopentiophenone (α-PVP) α-Pyrrolidinopentiothiophenone (α-PVT) α-Pyrrolidinohexiophenone (α-PHP) 4'-Methyl-α-pyrrolidinobutiophenone (MPBP) 3',4'-Methylenedioxy-α-pyrrolidinobutiophenone (MDPBP) Buphedrone
References